- Home
- BANC vs IRON Comparison
BANC vs IRON Comparison
Compare BANC & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANC
- IRON
- Stock Information
- Founded
- BANC 1941
- IRON 2017
- Country
- BANC United States
- IRON United States
- Employees
- BANC N/A
- IRON N/A
- Industry
- BANC Major Banks
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- BANC Finance
- IRON Health Care
- Exchange
- BANC Nasdaq
- IRON Nasdaq
- Market Cap
- BANC 2.3B
- IRON 2.0B
- IPO Year
- BANC N/A
- IRON N/A
- Fundamental
- Price
- BANC $16.29
- IRON $60.35
- Analyst Decision
- BANC Buy
- IRON Strong Buy
- Analyst Count
- BANC 11
- IRON 11
- Target Price
- BANC $17.18
- IRON $95.73
- AVG Volume (30 Days)
- BANC 2.0M
- IRON 325.5K
- Earning Date
- BANC 07-23-2025
- IRON 08-07-2025
- Dividend Yield
- BANC 2.57%
- IRON N/A
- EPS Growth
- BANC N/A
- IRON N/A
- EPS
- BANC 0.65
- IRON N/A
- Revenue
- BANC $949,659,000.00
- IRON N/A
- Revenue This Year
- BANC $8.71
- IRON N/A
- Revenue Next Year
- BANC $12.84
- IRON N/A
- P/E Ratio
- BANC $24.00
- IRON N/A
- Revenue Growth
- BANC 150.32
- IRON N/A
- 52 Week Low
- BANC $11.52
- IRON $30.82
- 52 Week High
- BANC $18.08
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- BANC 68.53
- IRON 57.22
- Support Level
- BANC $15.50
- IRON $57.54
- Resistance Level
- BANC $15.83
- IRON $64.83
- Average True Range (ATR)
- BANC 0.36
- IRON 2.14
- MACD
- BANC 0.10
- IRON -0.19
- Stochastic Oscillator
- BANC 96.54
- IRON 46.60
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.